New proteasome inhibitors in the treatment of multiple myeloma
The treatment of patients with relapsed and/or refractory multiple myeloma has improved considerably in the last 15 years, after the introduction of proteasome inhibitors and immunomodulatory drugs. The first clinical trials with new proteasome inhibitors have produced exciting results, particularly...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019-01-01
|
| coleção: | Hematology, Transfusion and Cell Therapy |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S253113791830124X |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|